第五章 鑑價分析
第二節 建議
生技產業是屬於知識密集的知識型經濟產業，如果可以利用其技術或專利 進行商業的交易活動，對生技產業的企業來說是一項非常利多的發展，對於其 技術的持續研發、或是產品的商業化發展來說，都是非常有幫助的。尤其以生 技藥品企業為例，研發其長達 10~15 年，如果在研發階段便能將其技術利用技 術鑑價對其技術價值有初步的瞭解，再透過資金募集的方式加以『有價化』，
增加該企業的資金投入，不僅使其研發得以延續，也提高了企業的競爭優勢。
因此，可以瞭解生技產業技術價值的彰顯，端賴於鑑價的運作，而如何建 立完整的鑑價機制以及市場，藉由成立成熟、且適合我國的生技產業的鑑價機 制，將可使生技產業的研發成果不用等到該技術真正能商品化，如此一來，更 能促使生技產業能更積極的投入研發，提昇我國生技產業的技術競爭優勢。
參考文獻
王本耀(2003)。我國智財權融資業務發展關鍵問題－智財交易與鑑價融資與談報 告。我國智財權融資業務發展關鍵問題座談會，台北市：台灣金融研訓院。
王本耀(2004)。國外智慧財產之鑑價與籌資。台灣技術交易整合服務中心鑑價人 員培訓講義，台北市。
王本耀、陳瑞田、鄭淑穎(2001)。技術交易市場運作機制之現況與發展趨勢。第 二屆工業技術研究院科技管理研討會，新竹縣：工業技術研究院。
王本耀、黃宗能(2000)。美國技術移轉措施與機制─兼論對我國的啟示。2000 全國科技法律研討會，新竹市：交通大學。
王惠鈞、吳啟佑(2003)，蛋白質體學之新進展。台北：ITIS 智網。
車慧中(2009)，以美國專利侵權訴訟判決建構專利鑑價模型之研究。未出版之博 士論文，私立中華大學科技管理研究所，新竹市。
車慧中(2004)。專利地圖全方位大攻略。專利地圖人才培訓研討會，新竹縣：工 業技術研究院。
陳宥杉、賴奎魁、施宜君、詹采璃(2008)。以專利分析探討油電混合車之發展現 況。環境與管理研究，
9(1)，46-70。
陳宥杉、賴奎魁、陳碧俞(2007)。預測產學合作研究計畫之技術移轉發展-以國 科會小產學為例。知識經濟學報，
2(1)，39-50。
陳宥杉、賴奎魁、陳碧俞、林複營(2007)。探討我國紡織業與自行車業之專利技 術研發現況。環球科技人文學刊，
5，25-40。
馮正民、邱裕鈞(2004)。研究分析方法。新竹市：建都文化事業有限公司。
湯谷清(2005)。生技產業技術鑑價模式分析。台北：ITIS 智網。
張孟元、劉江彬(2005)。無形資產評估鑑價之理論與實務。台北市：華泰文化。
廖美智(2008)。掌握全球生技產業脈動開創台灣新契機。2008 發現台灣建構未 來產業研討會，財團法人生物技術開發中心。
劉江彬、劉文卿、張孟元(2001)。技術價值關鍵指標之研究。資訊管理學報，
11(3)，80-120。
劉江彬、張孟元(2003)。技術及專利價值評估模式之研究。台大管理論叢，
12(1)，
37-83。
劉尚志、王敏銓、張宇樞、林明儀(2005)。Patent Wars美台專利訴訟
─
實戰暨裁 判解析。台北市：元照出版有限公司。賴以軒、車慧中、王思儀(2008)。以訴訟判決為基礎的人工智慧專利評價方法。
2008 華人經濟圈企業競爭力與經營管理學術研討會，新竹市：中華大學。
賴以軒、車慧中、王思儀(2008)。專利法律價值的評價模型。2008 全國科技法 律研討會，新竹市：交通大學。
賴以軒、車慧中、王思儀(2009)。整合線性迴歸暨倒傳遞神經網路建構專利法律 價值的評價模型。2009 兩岸系統性創新研討會，新竹市：清華大學。
賴以軒、車慧中(2010)。以倒傳遞神經網路建構專利法律價值的評價模型。台北 市：台大管理論叢。
賴以軒、車慧中、王思儀(2008)。以美國專利侵權訴訟判例為基礎的專利法律價 值鑑價模型。2008 績效評估與價值創造研討會，台中：中興大學。
賴以軒、車慧中、王思儀、李皞白、莊婷聿(2007)。模糊類神經網路方法建構專 利鑑價模型之研究。2007 中華萃思（TRIZ）學會第二屆學術與實務研討會，
新竹：清華大學。
賴奎魁、吳曉君(2004)。台灣半導體製造業公司技術定位之研究—使用專利資料。
商管科技季刊，5(2)，149-167。
賴奎魁、施育地、林東益(2004)。技術定位與技術策略群組—以台灣半導體封裝 產業為例。管理研究學報，4(1)，1-22。
賴奎魁、張善斌(2004)。建構商業方法技術擴散模式－整合專利引證及貝氏模 式。科技管理學刊，9(1)，1-34。
賴奎魁、鄭伶如、張智翔(2002)。運用專利資料探討接觸式影像感測器技術發展 趨勢之研究。科技管理學刊，7(1)，117- 136。
Cromley J. T, (2004). 20 Steps for Pricing a Patent . To value an invention you have to understand it. Journal of Accountancy, 198(5), 31-34.
David, J. T. ( 2000). Managing Intellectual Capital-Organizational, Strategic, and
Policy Dimensions. International Tax Review World Tax 2010. Oxford
University Press, 421-425Galbraith, J. K. (1967). The New Industrial State. New York: New York University Press
Lai, K. K., Lin, M. L. & Chang, S. M. (2006). Research trends on patent analysis:An analysis of the research published in librarys electonic database. The Journal of
American Academy of Business, 8(2), 248-253.
Lai, K. K., Su, F. P., Weng, C. S. & Chen, C. L. (2007). Co-opetition strategy from the patent analysis perspective: The case of the stent market. Internation
Journal of Innovation and Technology Management, 4(2), 137-153.
Lai, Y. H., Che, H. C. & Wang, S. Y. (2010). Assessment of Patent Legal Value by Regression and Back-Propagation Neural Network. International Journal of
Systematic Innovation, 1, 31-47.
Lai, Y. H. & Che, H. C. (2010). Modeling Patent Legal Value by Back Propagation Neural Network. NTU Management Review, 20, 147-178.
Lai, Y. H. & Che, H. C. (2009). Modeling patent legal value by extension neural network. Expert Systems with Applications, 36(7), 10520-10528.
Lai, Y. H. & Che, H. C. (2009). Evaluating patents using damage awards of infringement lawsuits: A case study. The Journal of Engineering and
Technology Management, 26, 167-180.
Lai, Y. H. & Che, H. C. (2009). Integrated evaluator extracted from infringement lawsuits using extension neural network accommodated to patent assessment.
The International Journal of Computer Applications in Technology, 35(2/3/4),
84-96.Lai, Y. H., WANG S. Y. & Che, H. C. (2010). Analysis and Study on the Growth Curve Application – A Case Study of Field Emitting Display. Science and
Technology Management Research, 30(z1).
Roots, J., G. Roos, N. Dragonetti, & L. Edvinsson (1997). Intellectual capital:
Navigation in the new business landscape. New York: New York University
Press.Smith, G. V. & Parr, R. L., (2000). Valuation of Intellectual Property and Intangible
Asset. New York: Jjohn Wiley & Sons.
Stewart, T. A. (1997). Intellectual capital: The new wealth of organizations.
Canada:Dell Publishing Group, Inc.
Thomas, P. (2001). A relationship between technology indicators and stock market performance. Scientometrics, 51(1), 319-333.
Tong, X. & Frame, J. D. (1994). Measuring national technological performance with patent claims data. Research Policy, 23(2), 133-141.
附錄
Publication Title Assignee EP1218494B1 COMPOSITIONS AND METHODS
FOR INHIBITING G2 CELL CYCLE ARREST AND SENSITIZING CELLS TO DNA DAMAGING AGENTS
Canbas Co., Ltd.
EP1313851B1 METHODS AND REAGENTS FOR MOLECULAR CLONING
INVITROGEN CORPORATION EP1410802A1 CELL DEATH INDUCERS FOR MAST
CELLS
Mitsubishi Pharma Corporation EP1652855A1 POLYPEPTIDES HAVING BRAIN
DISPOSITION ACTIVITY AND UTILIZATION OF THE SAME
TISSUE
TARGETING JAPAN INC.
US20020055139A1 Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses
HOLTZMAN DOUGLAS A.
US20020111471A1 Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death
COGENT
NEUROSCIENCE, INC.
US20020142299A1 PTD-modified proteins DAVIDSON BEVERLY L.
US20020160497A1 Suppressors of human breast cancer cell growth
MONTANO MONICA US20030022179A1 Methods and reagents for molecular
cloning
CHESNUT JONATHAN D.
US20030027998A1 Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses
HOLTZMAN DOUGLAS A.
US20030082561A1 Zinc finger domain recognition code and uses thereof
SERA TAKASHI US20030186233A1 Methods and compositions for synthesis
of nucleic acid molecules using multiple recognition sites
Invitrogen Corporation US20030235575A1 Identification of oligoadenylate
synthetase-like genes
WYETH
US20040053231A1 Transcription transactivator protein BHATTACHARYA SHOUMO
US20040053304A1 Methods and compositions for detecting cancers
Case Western Reserve University
US20040058856A1 Oligolysine transducing domain,
oligolysine-cargo molecule complex and uses thereof
CHOI SOO-YOUNG
US20040091878A1 Zinc finger domain recognition code and uses thereof
SERA TAKASHI US20040115184A1 Methods and compositions for modifying
apolipoprotein b mrna editing
SMITH HAROLD C US20040133933A1 Medane genes and proteins GUIMERA-VILARO
JORDI US20040146964A1 Assays, methods and means MAXWELL
PATRICK HENRY
Publication Title Assignee US20040180419A1 Combination therapy for treating protein
deficiency disorders
Mount Sinai School of Medicine of New York University
US20040248787A1 Cell death inducers for mast cells NAITO KOJI US20040265863A1 Methods and compositions for synthesis
of nucleic acid molecules using multiple recognition sites
Invitrogen Corporation US20050059116A1 Compositions and methods for inhibiting
G2 cell cycle arrest and sensitizing cells to DNA damaging agents
CanBas Co. Ltd.
US20050065333A1 Breast cancer-associated genes and uses
thereof SETH ARUN
US20050090646A1 Gene delivery to tumors SULLIVAN SEAN M.
US20050112640A1 PTD-modified proteins University of Iowa Research Foundation, a Iowa corporation US20050147971A1 Biomolecule transduction motif
mph-1-btm and the use thereof
LEE SANG-KYOU US20050170348A1 Nuclear-envelope and nuclear-lamina
binding chimeras for modulating gene expression
SERA TAKASHI
US20050203288A1 Peptides for inducing apoptosis in tumor cells
DEUTSCHES KREBSFORSCHUN GSZENTRUM STIFUNG DES OFFENTLICHEN RECHTS
US20050222386A1 Biomolecule transduction motif sim-2-btm and the use thereof
none US20050244969A1 Transient immortalization none US20050287648A1 Protein Transducing Domain/Deaminase
Chimeric Proteins, Related Compounds, and Uses Thereof
University of Rochester US20060025362A1 Guanylate binding protein (GBP-1) as
inhibitor of cell proliferation and
molecular marker for the determination of the stage of cellular differentiation
Sturzl; Prof. Dr. Rer.
Nat. Michael
US20060068473A1 Lactobacillus N-deoxyribosyl
transferases, corresponding nucleotide sequences and their uses
INSTITUT PASTEUR
US20060079674A1 Contraceptive targets Baylor College of Medicine Wyeth US20060084790A1 P-Rex1, a ptdins (3,4,5)
p3-g-beta-gamma-regulated
guanine-nucleotide exchange factor for rac
The Babraham Institute
US20060099677A1 DNA/RNA transduction technology and its clinical and basic applications
- US20060160732A1 Compositions and methods for inhibiting
cell senescence and hyperproliferative disorders
none
Publication Title Assignee US20060205034A1 Novel genes encoding proteins having
prognostic, diagnostic, preventive, therapeutic, and other uses
Millennium
Pharmaceuticals, Inc.
US20060216727A1 Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses
none
US20070021599A1 Methods and compositions for detecting cancers
Case Western Reserve University
US20070071724A1 Methods for increasing learning and memory in amyloid-beta-related
neurodegenerative disorders by increasing Uch-L1 activity and methods for
identifying enhancers of Uch-L1 activity
THE TRUSTEES OF COLUMBIA
UNIVERSITY IN THE CITY OF NEW YORK
US6277974 Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death
Cogent Neuroscience, Inc.
US6916632 Methods and reagents for molecular cloning
Invitrogen Corporation US7041474 Nucleic acid encoding human tango 509 Millennium
Pharmaceuticals, Inc.
US7198924 Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
Invitrogen Corporation WO0058352A2 BARLEY GENE FOR THIOREDOXIN
AND NADP-THIOREDOXIN REDUCTASE
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA WO0121631A2 SECRETED PROTEINS AND USES
THEREOF
MILLENNIUM PHARMACEUTICA LS, INC.
WO0121771A2 COMPOSITIONS AND METHODS FOR INHIBITING G2 CELL CYCLE ARREST AND SENSITIZING CELLS TO DNA DAMAGING AGENTS
CANBAS CO., LTD.
WO0123523A2 SECRETED PROTEINS AND USES THEREOF
MILLENNIUM PHARMACEUTICA LS, INC.
WO0168846A2 TRANSCRIPTION TRANSACTIVATOR PROTEIN
ISIS INNOVATION LIMITED
WO0176532A2 COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING CONDITIONS, DISORDERS, OR DISEASES INVOLVING CELL DEATH
COGENT
NEUROSCIENCE, INC.
WO0181361A1 COMPOSITIONS AND METHOD FOR DIAGNOSING AND TREATING CONDITIONS, DISORDERS, OR DISEASES INVOLVING CELL DEATH
COGENT
NEUROSCIENCE, INC.
WO02055684A2 PTD-MODIFIED PROTEINS UNIVERSITY OF IOWA RESEARCH FOUNDATION WO02055684A3 SYNTHETIC PROTEINS
CONTAINING A PROTEIN TRANSDUCTION DOMAIN
UNIVERSITY OF IOWA RESEARCH FOUNDATION
Publication Title Assignee WO02068676A2 METHODS AND COMPOSITIONS
FOR MODIFYING APOLIPOPROTEIN B mRNA EDITING
UNIVERSITY OF ROCHESTER WO02074981A2 ASSAYS, METHODS AND MEANS ISIS INNOVATION
LTD.
WO0208286A2 ZINC FINGER DOMAIN
RECOGNITION CODE AND USES THEREOF
SYNGENTA PARTICIPATIONS AG
WO02087507A2 BREAST CANCER-ASSOCIATED GENES AND USES THEREOF
SUNNYBROOK &
WOMEN'S
COLLEGE HEALTH SCIENCES CENTRE WO0216594A2 METHODS AND REAGENTS FOR
MOLECULAR CLONING
INVITROGEN CORPORATION WO0228879A1 SUPPRESSOR OF HUMAN BREAST
CANCER CELL GROWTH
CASE WESTERN RESERVE
UNIVERSITY WO0246372A1 METHODS AND COMPOSITIONS
FOR SYNTHESIS OF NUCLEIC ACID MOLECULES USING MULTIPLE RECOGNITION SITES
INVITROGEN CORPORATION
WO03025163A2 LACTOBACILLUS
N-DEOXYRIBOSYL TRANSFERASES, CORRESPONDING NUCLEOTIDE SEQUENCES AND THEIR USES
INSTITUT PASTEUR
WO03038441A2 SCREENING METHODS BASED ON CITED FAMILY PROTEINS
ISIS INNOVATION LTD
WO03059940A1 BIOMOLECULE TRANSDUCTION MOTIF SIM-2-BTM AND THE USE THEREOF
LEE, Sang-Kyou
WO03059941A1 BIOMOLECULE TRANSDUCTION MOTIF MPH-1-BTM AND THE USE THEREOF
LEE, Sang-Kyou
WO03062447A2 NUCLEAR-ENVELOPE AND NUCLEAR-LAMINA BINDING CHIMERAS FOR MODULATING GENE EXPRESSION
SYNGENTA PARTICIPATIONS AG
WO03091400A2 CONTRACEPTIVE TARGETS BAYLOR COLLEGE OF MEDECINE WO03103600A2 METHODS AND COMPOSITIONS
FOR SYNTHESIS OF NUCLEIC ACID MOLECULES USING MULTIPLE RECOGNITION SITES
INVITROGEN CORPORATION
WO03103600A2 METHODS AND COMPOSITIONS FOR SYNTHESIS OF NUCLEIC ACID MOLECULES USING MULTIPLE RECOGNITION SITES
INVITROGEN CORPORATION
WO03104427A2 METHODS AND COMPOSITIONS FOR DETECTING CANCERS
CASE WESTERN RESERVE
UNIVERSITY
Publication Title Assignee WO04013160A2 PROTEIN TRANSDUCING
DOMAIN/DEAMINASE CHIMERIC PROTEINS, RELATED COMPOUNDS, AND USES THEREOF
UNIVERSITY OF ROCHESTER
WO04016646A2 PEPTIDE MODULATORS OF TUMOUR SPECIFIC PYRUVATE KINASE SUBTYPE M2 (M2-PK)
AMYNON BIO TECH GMBH WO04044008A1 DNA/RNA TRANSDUCTION
TECHNOLOGY AND ITS CLINICAL AND BASIC APPLICATIONS
FORHUMANTECH CO., LTD.
WO04044124A2 IDENTIFICATION OF OLIGOADENYLATE
SYNTHETASE-LIKE GENES
BAYLOR COLLEGE OF MEDICINE WO04069190A2 COMBINATION THERAPY FOR
TREATING PROTEIN DEFICIENCY DISORDERS
MOUNT SINAI SCHOOL OF
MEDICINE OF NEW YORK UNIVERSITY WO04106543A1 AN IMPROVED GENETIC SCREEN
FOR INTERACTION INTERFACE MAPPING
PHYLOGICA LIMITED
WO04113497A2 GENE DELIVERY TO TUMORS UNIVERSITY OF FLORIDA
WO05001062A2 MODIFIED VECTORS FOR ORGANELLE TRANSFECTION
GENCIA
CORPORATION WO05037297A1 COMPOSITIONS AND METHODS
FOR INHIBITING CELL SENESCENCE AND HYPERPROLIFERATIVE
DISORDERS
ARONSON, Gary
WO05042583A1 EC SOD AND CELL TRANSDUCING EC SOD AND USE THEREOF
BIO CLUE &
SOLUTION CO., LTD.
WO05056752A2 METHODS AND COMPOSITIONS FOR DELIVERING
POLYNUCLEOTIDES
GENCIA
CORPORATION WO05071071A1 PTD-HUMAN CHOLINE
ACETYLTRANSFERASE FUSION PROTEIN AND ITS APPLICATION
INSTITUTE OF PHARMACOLOGY AND TOXICOLOY ACADEMY OF MILITARY MEDICAL SCIENCES P.L.A.
CHINA WO05074605A2 RECOMBINANT MOLECULAR
PRODUCTS FOR EXPRESSION OF HEME OXYGENASE-1, HEME OXYGENASE-2, AND/OR BILIVERDIN REDUCTASE FOR TREATMENT OF
NEURODEGENERATIVE DISEASES OR DISORDERS
UNIVERSITY OF ROCHESTER